-
Effectiveness of Oral Vancomycin in Preventing C diff Remains Uncertain after Trial
07 Jul 2025 15:55 GMT
Adding oral vancomycin to a systemic antibiotic treatment of a non- … PhD, Department of Medicine, School of Medicine and Public Health, University … vancomycin for prevention of recurrent Clostridioides difficile infection: A randomized clinical trial …
-
Oral Vancomycin Linked to Lower Clostridioides difficile Recurrence but Raises VRE Concerns: JAMA
05 Jul 2025 10:07 GMT
… a new randomized clinical trial that oral vancomycin reduced recurrent C. … oral vancomycin administered as prophylaxis with and after systemic antibiotic treatment might … prophylactic application. Larger, well-powered trials are needed to validate these …
-
Gastroenterology First Half Recap: 2025
09 Jul 2025 12:00 GMT
… US Food and Drug Administration (FDA) approvals of mirikizumab … phase 3 trials, including the GALAXI trials, which … treatment for primary CDI, highlighting its noninferiority to standard-of-care vancomycin … . The trial, which was …
-
Comparison of Subconjunctival Triamcinolone with Topical Prednisolone for Routine Anti-Inflammatory Prophylaxis in Manual Small Incision Cataract Surgery: A Single-Center, Randomized Controlled Trial Pilot Protocol
04 Jul 2025 00:34 GMT
… which includes the pilot trial.
Trial Design
Phase 1 … findings related to prophylaxis medication treatment (topical adherence for group … the Regulation of Clinical Trials in Humans, Ministerial … cefuroxime, moxifloxacin and vancomycin at the end of …
-
Regulatory tracker: With FDA filing, J&J targets Caplyta expansion into schizophrenia relapse prevention
02 Jul 2025 21:48 GMT
… sotatercept), the New Jersey drugmaker has locked in an … potentially update the medicine’s label.
The FDA has granted … Over in Europe, Vertex Pharmaceuticals is continuing to grow its … of the antibiotic vancomycin for the treatment of septicemia, infective …
-
Q2 2025 Recap: Gastroenterology News and Updates
07 Jul 2025 10:40 GMT
… full-spectrum microbiome drug, is safe, … 5 clinical trials highlighting the safety … of medicine at Rosalind Franklin University Chicago Medical … treatment for primary CDI, highlighting its noninferiority to standard-of-care vancomycin. The trial …
-
Transcriptomic Insights into Adaptive Strategies of Klebsiella pneumoniae Co-Producing KPC-2 and NDM-5 Carbapenemases Under Meropenem Stress
07 Jul 2025 11:53 GMT
… of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou … from the control (no drug treatment) and treated groups … the Gene Denovo Biotechnology (Guangzhou, China). … concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin …
-
Expert: Antimicrobial resistance is a ‘cancer care crisis’
09 Jul 2025 18:15 GMT
… MSCE, assistant professor of medicine in the division of … Healio. “Administering cancer treatment safely fundamentally depends on … 1,000 isolates) included vancomycin resistant Enterococcus spp (IRR … need, though, is in drug development.
“[Antimicrobials are] …
-
Clinical Features of Patients with Tropheryma Whipplei Detected in Lower Respiratory Tract Samples in China
09 Jul 2025 13:50 GMT
… infective regimen consisting of vancomycin, imipenem, cotrimoxazole, fluconazole … intravenous vancomycin, and inhaled amikacin. This treatment led to … or other immunosuppressive medications.
Results
The clinical … literature review. Infect Drug Resist. 2024;17 …
-
A Rare Case Report of Tropheryma Whipplei-Induced Acute Respiratory Distress Syndrome in an Immunocompetent Patient
08 Jul 2025 20:36 GMT
… switch from linezolid to vancomycin (15 mg/ … efficacy as a cornerstone drug for treating Tropheryma … considered immunocompetent based on medical history, a detailed immunological … Kusters JG. Clinical manifestations, treatment, and diagnosis of tropheryma …